Skip to content
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Adrenocortical Carcinoma
Cushing Syndrome
Musculoskeletal
Vitamin D Deficiency
Testosterone Deficiency
Products & Pipeline
Binosto® ‑ Worldwide
Rare Diseases ‑ Switzerland
Musculoskeletal ‑ Switzerland
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Adrenocortical Carcinoma
Cushing Syndrome
Musculoskeletal
Vitamin D Deficiency
Testosterone Deficiency
Products & Pipeline
Binosto® ‑ Worldwide
Rare Diseases ‑ Switzerland
Musculoskeletal ‑ Switzerland
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Adrenocortical Carcinoma
Cushing Syndrome
Musculoskeletal
Vitamin D Deficiency
Testosterone Deficiency
Products & Pipeline
Binosto® ‑ Worldwide
Rare Diseases ‑ Switzerland
Musculoskeletal ‑ Switzerland
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Adrenocortical Carcinoma
Cushing Syndrome
Musculoskeletal
Vitamin D Deficiency
Testosterone Deficiency
Products & Pipeline
Binosto® ‑ Worldwide
Rare Diseases ‑ Switzerland
Musculoskeletal ‑ Switzerland
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Adrenocortical Carcinoma
Cushing Syndrome
Musculoskeletal
Vitamin D Deficiency
Testosterone Deficiency
Products & Pipeline
Binosto® ‑ Worldwide
Rare Diseases ‑ Switzerland
Musculoskeletal ‑ Switzerland
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Adrenocortical Carcinoma
Cushing Syndrome
Musculoskeletal
Vitamin D Deficiency
Testosterone Deficiency
Products & Pipeline
Binosto® ‑ Worldwide
Rare Diseases ‑ Switzerland
Musculoskeletal ‑ Switzerland
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Adrenocortical Carcinoma
Cushing Syndrome
Musculoskeletal
Vitamin D Deficiency
Testosterone Deficiency
Products & Pipeline
Binosto® ‑ Worldwide
Rare Diseases ‑ Switzerland
Musculoskeletal ‑ Switzerland
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Adrenocortical Carcinoma
Cushing Syndrome
Musculoskeletal
Vitamin D Deficiency
Testosterone Deficiency
Products & Pipeline
Binosto® ‑ Worldwide
Rare Diseases ‑ Switzerland
Musculoskeletal ‑ Switzerland
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
News
Stay updated with the latest developments, that define our journey towards healthcare innovation
June 25, 2026
|
News
,
Newsroom
EffRx Supports SHG Wegweiser Through Employee Donation
June 10, 2026
|
News
,
Newsroom
EffRx Attending the BIO International Convention 2026 in San Diego
April 21, 2026
|
News
,
Newsroom
EffRx Attending Swiss Biotech Day 2026 in Basel, May 4-5, 2026
March 26, 2026
|
News
,
Newsroom
EffRx Attending the 53rd ECTS 2026 Congress, Girona, Apr 24–27
March 18, 2026
|
News
,
Newsroom
EffRx Attending the WCO-IOF-ESCEO Congress, Prague, Apr 16–19, 2026
February 28, 2026
|
News
,
Newsroom
Rare Diseases Day
February 5, 2026
|
News
,
Newsroom
EffRx Attending the 65th Ärztekongress in Davos
October 23, 2025
|
News
,
Newsroom
EffRx Attending Jefferies London Healthcare Conference, Nov 17–20, 2025
September 30, 2025
|
News
,
Newsroom
EffRx Attending BIO-Europe 2025, Vienna,Austria Nov 3–5
June 2, 2025
|
News
,
Newsroom
EffRx Attending BIO 2025 in Boston June 16-19, 2025
May 22, 2025
|
News
,
Newsroom
EffRx attending the ECTS Congress, Innsbruck, May 23–26, 2025
January 7, 2025
|
News
,
Newsroom
EffRx Pharmaceuticals Joins scienceindustries (Swiss business association)
December 5, 2024
|
News
,
Newsroom
EffRx Joins SHQA (swiss health quality association)
June 3, 2024
|
News
,
Newsroom
EffRx Attending the BIO International Convention in San Diego
April 8, 2024
|
News
,
Newsroom
EffRx Attending the 2024 WCO IOF-ESCEO Congress in London
February 28, 2024
|
News
,
Newsroom
EffRx is a Proud Supporter of Rare Disease Day, February 28
January 25, 2024
|
News
,
Newsroom
EffRx Attending the Annual Meeting SSEDP/SGPED, Jan 25, 2024, Berne
July 12, 2023
|
News
World Orphan Drug Alliance (WODA) Marks their First Anniversary
May 4, 2023
|
News
EffRx Attends the WCO IOF-ESCEO Congress
February 21, 2023
|
News
EffRx Supports the 16th Annual Rare Disease Day on 28. February 2023
January 24, 2023
|
News
EffRx Attending the Annual Meeting SSEDP/SGPED, Jan 26, 2023
December 20, 2022
|
News
EffRx Attends the 1st Eastern Switzerland Rare Disease Symposium
July 13, 2022
|
News
EffRx Attending the 9th I-DSD Symposium 2022 in Bern, Switzerland, University Hospital Bern from 14-16th July 2022
July 6, 2022
|
News
EffRx Featured as Member of WODA in Rare Revolution Magazine